Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 352 resultados

RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado

IQ-BRAIN: Improving QMRI By Realizing trustworthy integration of AI in Neuro imaging MRI is a key methodology in modern neuroimaging, but conventional MRI relies on visual interpretation of intensity differences in the images...
2024-06-25 - 2028-11-30 | Financiado

INFRAPLUS: Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: HORIZON-INFRA-2023-DEV-01 In response to the HORIZON-INFRA-2023-DEV-01-03 call, INFRAPLUS aims to expand INFRAFRONTIER's capacity for human disease modelling, refine...
2024-06-20 - 2027-05-31 | Financiado

SPACETIME: SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 The introduction of immune checkpoint therapy for Non-Small Cell Lung Cancer (NSCLC) has improved clinical outcomes. However, due to primary...
2024-06-03 - 2029-07-31 | Financiado

Acyl-STEP-seq: Investigating the functional roles of histone acylation co-occurrence on transcription in single-cel... HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Regulation of transcription is orchestrated by a complex combination of histone posttranslational modifications (PTMs), but how their co-occ...
2024-05-21 - 2027-06-30 | Financiado

RRMs-lncRNA: Deciphering the Recognition, Recruitment and Modification of structured lncRNAs by the methyl-transf... HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 The human METTL3/METTL14 methyltransferase complex (MTC) is responsible for the m6A methylation of a large set of RNAs, and plays a crucial...
2024-03-26 - 2026-05-14 | Financiado

DOG-AMP: Deep optimized generation for antimicrobial peptide discovery HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2023-COG The DOG-AMP project will develop cutting-edge methods for Deep Optimized Generation (DOG), and use them to transform the emerging field of A...
2024-03-19 - 2029-04-30 | Financiado

TACOS: Towards an Artificial Cognitive Science HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2023-STG With the advent of capable artificial agents comes the urgency to improve our understanding of how they learn, reason, and decide. This prop...
2023-12-05 - 2028-12-31 | Financiado

LeukoScreen: AI-based leukemia detection in routine diagnostic blood smear data HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 Acute promyelocytic leukemia is an extremely aggressive blood cancer where immediate diagnosis can determine life or death. The diagnostic s...
2023-11-03 - 2025-05-31 | Financiado

RESIST: Resilient Oats: Improving Drought Stress Resistance in a Changing Climate HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: ERC-2023-STG Providing food security in the face of climate change and increasingly frequent extreme heat and drought events is one of the greatest globa...
2023-11-03 - 2029-03-31 | Financiado

PREDICT THE DRUG: Using ex vivo functional genomics as biomarker to predict the effectivity of Venetoclax in patients... HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 For decades, oncologists treating cancer patients desire biomarkers that predict drug sensitivity on a patient individual level; unfortunate...
2023-10-26 - 2025-06-30 | Financiado

BETTER4U: Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you BETTER4U HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage BETTER4U aims at the identification and personalized management of all weight gain determinants to battle the increasingly rising numbers of...
2023-10-23 - 2027-10-31 | Financiado

REGENERAR: IMPROVING THE EFFECTIVENESS AND SAFETY OF EPIGENETIC EDITING IN BRAIN REGENERATION HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 The central nervous system has a limited capacity for self-repair. Therefore, technologies to replace lost neurons after an injury, includin...
2023-10-06 - 2028-02-29 | Financiado

AiChemist: Explainable AI for Molecules - AiChemist HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Optimising biological activity and physico-chemical properties, while minimising their toxicity, are objectives when developing new compound...
2023-09-01 - 2027-08-31 | Financiado

HMGU